相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of pAKT as a pharmacodynamic marker for MER kinase in human melanoma G361 cells
Yaoyu Chen et al.
BIOMARKER RESEARCH (2020)
Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor
Yumi Yokoyama et al.
CANCER RESEARCH (2019)
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
Kayla V. Myers et al.
MOLECULAR CANCER (2019)
Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1
Thomas A. Werfel et al.
CANCER RESEARCH (2019)
Characterization of INCB081776, a potent and selective dual AXL/MER kinase inhibitor
Margaret Favata et al.
CANCER RESEARCH (2018)
Augmentation of Human Monocyte Responses to Lipopolysaccharide by the Protein S and Mer/Tyro3 Receptor Tyrosine Kinase Axis
Nicole D. Barth et al.
JOURNAL OF IMMUNOLOGY (2018)
MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
Nellie K. McDaniel et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies
Marie Schoumacher et al.
CURRENT ONCOLOGY REPORTS (2017)
Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma
Carmela Dantas-Barbosa et al.
BRITISH JOURNAL OF CANCER (2017)
AXL-Driven EMT State as a Targetable Conduit in Cancer
Jane Antony et al.
CANCER RESEARCH (2017)
TAM Receptor Tyrosine Kinases in Cancer Drug Resistance
Mikaella Vouri et al.
CANCER RESEARCH (2017)
Monocyte differentiation and antigen-presenting functions
Claudia V. Jakubzick et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease
Jenny Potratz et al.
MOLECULAR ONCOLOGY (2016)
Role of AXL expression in non-small cell lung cancer
Xiaohan Qu et al.
ONCOLOGY LETTERS (2016)
The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy
Magdalena Paolino et al.
CANCERS (2016)
TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis
Jonathan H. M. van der Meer et al.
BLOOD (2014)
AXL Mediates Resistance to Cetuximab Therapy
Toni M. Brand et al.
CANCER RESEARCH (2014)
A Quantitative Method for Measuring Innate Phagocytosis by Human Monocytes Using Real-Time Flow Cytometry
Ben J. Gu et al.
CYTOMETRY PART A (2014)
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution
Jamie C. Stanford et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Axl Kinase as a Key Target for Oncology: Focus on Small Molecule Inhibitors
Clemence Feneyrolles et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Diversification of TAM receptor tyrosine kinase function
Anna Zagorska et al.
NATURE IMMUNOLOGY (2014)
The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma
Emmy D. G. Fleuren et al.
ONCOTARGET (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
T Cell-Derived Protein S Engages TAM Receptor Signaling in Dendritic Cells to Control the Magnitude of the Immune Response
Eugenio A. Carrera Silva et al.
IMMUNITY (2013)
MERTK receptor tyrosine kinase is a therapeutic target in melanoma
Jennifer Schlegel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer
R. M. A. Linger et al.
ONCOGENE (2013)
Efficient Clearance of Early Apoptotic Cells by Human Macrophages Requires M2c Polarization and MerTK Induction
Gaetano Zizzo et al.
JOURNAL OF IMMUNOLOGY (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Targeting Axl and Mer Kinases in Cancer
Anupam Verma et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Immunobiology of the TAM receptors
Greg Lemke et al.
NATURE REVIEWS IMMUNOLOGY (2008)
TAM receptors are pleiotropic inhibitors of the innate immune response
Carla V. Rothlin et al.
CELL (2007)
Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase
PL Cohen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family
QX Lu et al.
SCIENCE (2001)
分享论文
